author-photo

Mawar Karsa

University of New South Wales

16

Papers

58

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Dual targeting of chromatin stability by the curaxin CBL0137 and histone deacetylase inhibitor panobinostat shows significant preclinical efficacy in neuroblastoma.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.

2021 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction

2019 Oncogene
Show All
- Source
- Cite
- Save
Citations (12)
PO-405 Repositioning existing drugs as novel therapeutics for high-risk paediatric leukaemia

2018
Show All
- Source
- Cite
- Save
Citations (0)
PO-405 Repositioning existing drugs as novel therapeutics for high-risk paediatric leukaemia

2018
Show All
- Source
- Cite
- Save
Citations (0)
PO-405 Repositioning existing drugs as novel therapeutics for high-risk paediatric leukaemia

2018
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1175: Inhibition of NAMPT as a novel therapeutic strategy for infant leukemia

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (8)
Improved Concordance of Minimal Residual Disease Measurements By Quantitative PCR and 10-Color Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
The value of monitoring for MRD at late timepoints in paediatric all treatment

2011 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (0)